Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.

Affiliation

Adrielle Dos Santos L(1), Filho PGG(1), Silva AMF(1), Santos JVG(1), Santos DS(1), Aquino MM(1), de Jesus RM(2), Almeida MLD(1), da Silva JS(3), Altmann DM(4), Boyton RJ(5), Alves Dos Santos C(6), Santos CNO(7), Alves JC(7), Santos IL(7), Magalhães LS(7), Belitardo EMMA(8), Rocha DJPG(8), Almeida JPP(9), Pacheco LGC(8), Aguiar ERGR(10), Campos GS(11), Sardi SI(11), Carvalho RH(11), de Jesus AR(12), Rezende KF(1), de Almeida RP(13).
Author information:
(1)Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute
(III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil.
(2)Division of Pulmonology, Institute of Health Promotion and Assistance for Employees of the State of Sergipe
(IPESAÚDE), Sergipe, Brazil.
(3)Fiocruz - Bi-Institutional Translational Medicine Project, Ribeirao Preto Medical School, Department of Biochemistry and Immunology, 14049-900 Ribeirao Preto, SP, Brazil.
(4)Department of Immunology and Inflammation, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, W12 ONN, United Kingdom. Electronic address: [Email]
(5)Department of Immunology and Inflammation, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, W12 ONN, United Kingdom.
(6)Health Foundation Parreiras Horta, Central Laboratory of Public Health
(LACEN/SE), State Secretary for Health, Sergipe, Brazil.
(7)Division of Immunology and Molecular Biology Laboratory, University Hospital/EBSERH, Federal University of Sergipe, Sergipe CEP 49.060-025, Brazil.
(8)Institute of Health Sciences, Federal University of Bahia, Salvador-BA, Brazil.
(9)Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte-MG, Brazil.
(10)Department of Biological Sciences, Center of Biotechnology and Genetics, State University of Santa Cruz
(UESC), Ilhéus-BA, Brazil.
(11)Virology Laboratory, Institute of Health Sciences, Federal University of Bahia, Salvador-BA, Brazil.
(12)Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute
(III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil; Division of Immunology and Molecular Biology Laboratory, University Hospital/EBSERH, Federal University of Sergipe, Sergipe CEP 49.060-025, Brazil.
(13)Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute
(III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil; Division of Immunology and Molecular Biology Laboratory, University Hospital/EBSERH, Federal University of Sergipe, Sergipe CEP 49.060-025, Brazil. Electronic address: [Email]

Abstract

Comment in J Infect. 2021 Jun;82(6):e16-e17. J Infect. 2021 Jun;82(6):276-316. J Infect. 2021 Aug;83(2):237-279.